Acute Angle-Closure Attacks Are Uncommon in Primary Angle-Closure Suspects after Pharmacologic Mydriasis: The Zhongshan Angle-Closure Prevention Trial.
Ophthalmol Glaucoma
; 5(6): 581-586, 2022.
Article
in En
| MEDLINE
| ID: mdl-35568336
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glaucoma, Angle-Closure
/
Mydriasis
/
Laser Therapy
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limits:
Aged
/
Humans
/
Middle aged
Language:
En
Journal:
Ophthalmol Glaucoma
Year:
2022
Document type:
Article
Country of publication:
United States